India · Series B startup

Who invested in Medgenome Labs

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$24Mraised across 2 rounds since 2014, from 2 sources

$4.0MSeries A$20MSeries B
Latest round
Series B, $20MJul 2015
Step-upi
5×
Investors
3
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2015
$4.0MSeries A$20MSeries B
First round
Series A, $4.0M
Jun 2014
Biggest round
$20M
Series B · Jul 2015
Between rounds
14 months
from the last two

The rounds

  1. Jul 2015
    Series B$20M1 new

    From a historical funding record

  2. Jun 2014
    Series A$4.0M2 new

    From a historical funding record

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Sequoia CapitalVC firm1round
Emerge EducationVC firm1round
Papillon CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Medgenome Labs

Who invested in Medgenome Labs?

Medgenome Labs's investors include Sequoia Capital, Emerge Education and Papillon Capital.

How much has Medgenome Labs raised?

Medgenome Labs has raised $24M across 2 rounds since 2014.

When did Medgenome Labs last raise?

Medgenome Labs's most recent round was a Series B of $20M in Jul 2015.

What was Medgenome Labs's biggest round?

Its most recent round, $20M in Jul 2015, is also its largest on record.

Who backed Medgenome Labs first?

Medgenome Labs's first round on record, in Jun 2014, was backed by Emerge Education and Papillon Capital.

What stage is Medgenome Labs at?

Medgenome Labs's latest named round is a Series B, in Jul 2015.

Where is Medgenome Labs based?

Medgenome Labs is based in India.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.